3'-P-HYDROXY PACLITAXEL
|
|
3'-P-HYDROXY PACLITAXEL Eigenschaften
- Schmelzpunkt:
- 182-184°C
- storage temp.
- −20°C
- L?slichkeit
- Chloroform (Sparingly), Methanol (Slightly)
- Aggregatzustand
- solid
- Farbe
- White to Off-White
Sicherheit
WGK Germany | 3 | ||
---|---|---|---|
HS Code | 30049090 |
3'-P-HYDROXY PACLITAXEL Chemische Eigenschaften,Einsatz,Produktion Methoden
Chemische Eigenschaften
White SolidVerwenden
A metabolite of Paclitaxel; a phase I pharmacokinetic study in patients with solid tumors.3'-P-HYDROXY PACLITAXEL Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
3'-P-HYDROXY PACLITAXEL Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 25)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
China National Standard Pharmaceutical Corporation Limited | +8615391658522 |
overseasales@yongstandards.com | China | 11922 | 58 |
J & K SCIENTIFIC LTD. | 010-82848833 400-666-7788 |
jkinfo@jkchemical.com | China | 96815 | 76 |
Chemsky(shanghai)International Co.,Ltd. | 021-50135380 |
shchemsky@sina.com | China | 32321 | 50 |
BOC Sciences | 1-631-485-4226; 16314854226 |
info@bocsci.com | United States | 14055 | 65 |
Shanghai Tauto Biotech Co., Ltd. | 021-51320588 |
tauto@tautobiotech.com | China | 3989 | 66 |
Cato Research Chemicals Inc. | 020-81960175 |
min.he@cato-chem.com | China | 1955 | 55 |
BOC Sciences | 16314854226 |
info@bocsci.com | United States | 9923 | 65 |
Shenzhen Polymeri Biochemical Technology Co., Ltd. | +86-400-002-6226 +86-13028896684; |
sales@rrkchem.com | China | 57423 | 58 |
Shenzhen ruikai de biotechnology co., ltd. | 0755-61348847 17820674378 |
2682116078@qq.com | China | 7843 | 58 |
Hubei Xinyang Medical Technology Co., Ltd | 15347293736 15347293736 |
2853117764@qq.com | China | 8933 | 58 |
- 3'-P-HYDROXY PACLITAXEL
- P-3'-HYDROXYPACLITAXEL STANDARD
- [2aR-[2aα,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-β-(BenzoylaMino)-α,4-dihydroxy-benzenepropanoic Acid 6,12b-Bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetraMethyl-4-oxo-7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl Ester
- 3'-Para-hydroxypaclitaxel
- Benzenepropanoic acid, β-(benzoylamino)-α,4-dihydroxy-, (2aR,4S,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-4,11-dihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- 3'-p-Hydroxy Paclitaxel 3'-p-Hydroxy Paclitaxel
- 3’-p-Hydroxy Paclitaxel (1mg/mL in Dimethyl Sulfoxide)
- HYDROXYTAXOL, 3'-P-
- 6alpha,3'-p-Dihydroxy Paclitaxel-d5
- 3'-p-Hydroxytaxol
- 3’-p-Hydroxy Paclitaxel
- 132160-32-8
- Drug and Xenobiotic Metabolism
- Multi-Drug Resistance and Drug Metabolism
- Substrates, Inducers, Inhibitors
- Chiral Reagents
- Intermediates & Fine Chemicals
- Metabolites & Impurities
- Pharmaceuticals